SI9300244A - Novi kinazolini kot inhibitorji HIV reverzne transkriptaze - Google Patents
Novi kinazolini kot inhibitorji HIV reverzne transkriptaze Download PDFInfo
- Publication number
- SI9300244A SI9300244A SI9300244A SI9300244A SI9300244A SI 9300244 A SI9300244 A SI 9300244A SI 9300244 A SI9300244 A SI 9300244A SI 9300244 A SI9300244 A SI 9300244A SI 9300244 A SI9300244 A SI 9300244A
- Authority
- SI
- Slovenia
- Prior art keywords
- chloro
- cyclopropyl
- dihydro
- quinazolin
- pyridyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88011992A | 1992-05-07 | 1992-05-07 | |
US99116492A | 1992-12-16 | 1992-12-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
SI9300244A true SI9300244A (sl) | 1993-12-31 |
Family
ID=27128564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI9300244A SI9300244A (sl) | 1992-05-07 | 1993-05-07 | Novi kinazolini kot inhibitorji HIV reverzne transkriptaze |
Country Status (15)
Country | Link |
---|---|
EP (2) | EP0639184A1 (de) |
JP (1) | JPH0813805B2 (de) |
KR (1) | KR950701322A (de) |
CN (1) | CN1085550A (de) |
AU (2) | AU4220493A (de) |
BG (1) | BG99149A (de) |
CA (1) | CA2095194A1 (de) |
CZ (1) | CZ272494A3 (de) |
FI (1) | FI945199A (de) |
HR (1) | HRP930857A2 (de) |
HU (1) | HUT71401A (de) |
IL (1) | IL105551A0 (de) |
MX (1) | MX9302681A (de) |
SI (1) | SI9300244A (de) |
WO (1) | WO1993022292A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2281297A (en) * | 1993-08-27 | 1995-03-01 | Merck & Co Inc | Quinazoline compounds |
US5434152A (en) * | 1993-11-08 | 1995-07-18 | Merck & Co., Inc. | Asymmetric synthesis of (S)-(-)-6-chloro-4- cyclopropyl-3,4-dihydro-4-[(2-pyridyl)ethynyl]-2(1H)-quinazolinone |
US6124302A (en) | 1997-04-09 | 2000-09-26 | Dupont Pharmaceuticals | 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors |
HRP980143A2 (en) * | 1997-04-09 | 1999-02-28 | Soo Sung Ko | 4,4-disubstituted-3,4-dihydro-2 (1h)-quinazolinones useful as hiv reverse transcriptase inhibitors |
CA2333643A1 (en) * | 1998-06-30 | 2000-01-06 | James D. Rodgers | Substituted quinolin-2(1h)-ones useful as hiv reverse transcriptase inhibitors |
WO2000073284A2 (en) | 1999-05-26 | 2000-12-07 | Du Pont Pharmaceuticals Company | 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors |
EP1189882A1 (de) * | 2000-04-25 | 2002-03-27 | SAMSUNG ELECTRONICS Co. Ltd. | Biphenyl-butansäure-derivate als inhibitoren der matrix-metalloproteinase |
US7119111B2 (en) * | 2002-05-29 | 2006-10-10 | Amgen, Inc. | 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use |
ES2549084T3 (es) * | 2007-10-05 | 2015-10-22 | Msd K.K. | Derivados de benzoxazinona |
CN101544630B (zh) * | 2009-05-13 | 2013-03-13 | 中国科学院广州生物医药与健康研究院 | 羟基化茚地那韦的制备方法 |
EP3317278B1 (de) | 2015-07-01 | 2021-04-14 | Crinetics Pharmaceuticals, Inc. | Somatostatinmodulatoren und verwendungen davon |
EP3658560A4 (de) | 2017-07-25 | 2021-01-06 | Crinetics Pharmaceuticals, Inc. | Somatostatinmodulatoren und verwendungen davon |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL147140B (nl) * | 1968-11-26 | 1975-09-15 | Farmaceutici Italia | Werkwijze voor het bereiden van geneesmiddelen met een remmende werking op het centrale zenuwstelsel. |
IL102764A0 (en) * | 1991-08-16 | 1993-01-31 | Merck & Co Inc | Quinazoline derivatives,and pharmaceutical compositions containing them |
-
1993
- 1993-04-28 KR KR1019940703948A patent/KR950701322A/ko not_active Application Discontinuation
- 1993-04-28 WO PCT/US1993/003975 patent/WO1993022292A1/en not_active Application Discontinuation
- 1993-04-28 HU HU9403187A patent/HUT71401A/hu unknown
- 1993-04-28 AU AU42204/93A patent/AU4220493A/en not_active Abandoned
- 1993-04-28 EP EP93910860A patent/EP0639184A1/de not_active Withdrawn
- 1993-04-28 CZ CZ942724A patent/CZ272494A3/cs unknown
- 1993-04-29 CA CA002095194A patent/CA2095194A1/en not_active Abandoned
- 1993-04-29 EP EP93201232A patent/EP0569083A1/de not_active Withdrawn
- 1993-04-29 IL IL105551A patent/IL105551A0/xx unknown
- 1993-05-05 HR HR930857A patent/HRP930857A2/hr not_active Application Discontinuation
- 1993-05-06 AU AU38413/93A patent/AU3841393A/en not_active Abandoned
- 1993-05-06 MX MX9302681A patent/MX9302681A/es unknown
- 1993-05-06 CN CN93107074A patent/CN1085550A/zh active Pending
- 1993-05-07 JP JP5107015A patent/JPH0813805B2/ja not_active Expired - Lifetime
- 1993-05-07 SI SI9300244A patent/SI9300244A/sl unknown
-
1994
- 1994-10-31 BG BG99149A patent/BG99149A/xx unknown
- 1994-11-04 FI FI945199A patent/FI945199A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
JPH0813805B2 (ja) | 1996-02-14 |
FI945199A0 (fi) | 1994-11-04 |
JPH069578A (ja) | 1994-01-18 |
AU4220493A (en) | 1993-11-29 |
FI945199A (fi) | 1994-11-04 |
BG99149A (en) | 1995-06-30 |
CN1085550A (zh) | 1994-04-20 |
CA2095194A1 (en) | 1993-11-08 |
MX9302681A (es) | 1994-05-31 |
EP0639184A1 (de) | 1995-02-22 |
HUT71401A (en) | 1995-11-28 |
HRP930857A2 (en) | 1995-06-30 |
EP0569083A1 (de) | 1993-11-10 |
CZ272494A3 (en) | 1995-10-18 |
AU3841393A (en) | 1993-11-11 |
IL105551A0 (en) | 1993-08-18 |
WO1993022292A1 (en) | 1993-11-11 |
KR950701322A (ko) | 1995-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1995012583A1 (en) | New quinazolines as inhibitors of hiv reverse transcriptase | |
AU676563B2 (en) | HIV protease inhibitors useful for the treatment of AIDS | |
JP4625838B2 (ja) | Hivインテグラーゼ阻害薬 | |
EP0766674B1 (de) | Neue hiv-protease-inhibitoren | |
WO1993004047A1 (en) | Quinazoline derivatives as inhibitors of hiv reverse transcriptase | |
EP0617968B1 (de) | HIV Protease Hemmer in pharmazeutischen Zusammensetzungen zur Behandlung von AIDS | |
US5807841A (en) | HIV protease inhibitors useful for the treatment of AIDS | |
JP2008537741A (ja) | P2x7調節因子としてのビシクロヘテロアリール化合物およびそれらの使用 | |
KR20010075268A (ko) | 시아노페닐 유도체 | |
PL175615B1 (pl) | Benzoksazynony będące inhibitorami odwrotnej transkryptazy HIV, zawierające je środki farmaceutyczne oraz sposób wytwarzania (-)-6-chloro-4-cyklopropyloetynylo-4-trifluorometylo-1,4-dihydro-2H-3,1-benzoksazyn-2-onu | |
SI9300244A (sl) | Novi kinazolini kot inhibitorji HIV reverzne transkriptaze | |
WO1998042666A1 (en) | Novel 3,4-dialkoxyphenyl derivatives and the use thereof | |
US5846978A (en) | HIV protease inhibitors useful for the treatment of AIDS | |
GB2271566A (en) | HIV integrase inhibitors | |
US5650412A (en) | HIV protease inhibitors useful for the treatment of AIDS | |
CA2269135A1 (en) | Benzodiazepine hydrazide derivatives as inhibitors of hiv integrase | |
US5939414A (en) | Benzodiazepine hydrazide derivatives as inhibitors of HIV integrase | |
DE68906617T2 (de) | Substituierte 5,6,7,8-tetrahydroimidazo(1,5-a)pyridine und verfahren zu ihrer herstellung. | |
US5747540A (en) | HIV protease inhibitors useful for the treatment of AIDS | |
EP0914125A1 (de) | HIV-Proteaseinhibitoren, nützlich in der AIDS-Behandlung. |